Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase NA 1

Status

Completed 64Terminated 18Withdrawn 6Unknown 6Recruiting 5Active not recruiting 3Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 4OTHER_GOV 1INDIV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 5Plasma cell 2Other hematologic neoplasm 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Hodgkin Disease 1Autologous Stem Cell Transplantation 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × plerixafor × Clear all
NCT06141304 2023-11-21

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

The First Hospital of Jilin University

Phase 2 Unknown
28 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05510544 2023-03-13

Plerixafor for Poorly Mobilized Lymphoma

Peking University

Phase 4 Unknown
140 enrolled
Lymphoid

Lymphoma

NCT02605460 2020-01-14

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03244930 2017-08-10

Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation

Hospital Universitario Dr. Jose E. Gonzalez

Phase 2 Unknown
20 enrolled
LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

NCT02006225 2013-12-10

GCSF

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
30 enrolled

Autologous Stem Cell Transplantation

NCT01042717 2011-09-27

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Shi, Patricia, M.D.

Phase NA Unknown
10 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡